Patents by Inventor Bruno Franc

Bruno Franc has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Form of irbesartan, processes for obtaining the said and pharmaceutical compositions containing it
    Patent number: 7008959
    Abstract: The invention relates to a novel crystalline form of irbesartan to pharmaceutical compositions containing it, to processes for preparing it, and to a method for treating cardiovascular diseases utilizing it.
    Type: Grant
    Filed: September 9, 2004
    Date of Patent: March 7, 2006
    Assignee: Sanofi-Aventis
    Inventors: Bruno Franc, Christian Hoff, San Kiang, Mark D. Lindrud, Olivier Monnier, Chenkou Wei
  • Novel form of irbesartan, processes for obtaining the said and pharmaceutical compositions containing it
    Publication number: 20050032862
    Abstract: The invention relates to a novel crystalline form of irbesartan, to pharmaceutical compositions containing it, to processes for preparing it, and to a method for treating cardiovascular diseases utilizing it.
    Type: Application
    Filed: September 9, 2004
    Publication date: February 10, 2005
    Inventors: Bruno Franc, Christian Hoff, San Kiang, Mark Lindrud, Olivier Monnier, Chenkou Wei
  • Form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
    Patent number: 6800761
    Abstract: The invention relates to a novel crystalline form of irbesartan, to pharmaceutical compositions containing it, to processes for preparing it, and to a method for treating cardiovascular diseases utilizing it.
    Type: Grant
    Filed: March 12, 2001
    Date of Patent: October 5, 2004
    Assignee: Sanofi-Synthelabo
    Inventors: Bruno Franc, Christian Hoff, San Kiang, Mark D. Lindrud, Olivier Monnier, Chenkou Wei
  • Method for the crystallization of a tetrahydropyridin derivative and resulting crystalline forms
    Patent number: 6489334
    Abstract: The invention relates to a method of crystallizing a tetrahydropyridine derivative, to the novel crystalline forms thereby obtained and to the pharmaceutical compositions containing said tetrahydropyridine derivative in a given crystalline form as the active principle.
    Type: Grant
    Filed: September 6, 2001
    Date of Patent: December 3, 2002
    Assignee: Sanofi-Synthelabo
    Inventors: Antoine Caron, Bruno Franc, Olivier Monnier
  • Method for the crystallisation of a tetrahydropyridin derivative and resulting crystalline forms
    Publication number: 20020026057
    Abstract: The invention relates to a method of crystallizing a tetrahydropyridine derivative, to the novel crystalline forms thereby obtained and to the pharmaceutical compositions containing said tetrahydropyridine derivative in a given crystalline form as the active principle.
    Type: Application
    Filed: September 6, 2001
    Publication date: February 28, 2002
    Inventors: Antoine Caron, Bruno Franc, Olivier Monnier
  • Process for obtaining procyanidol oligomers from plants by extractions
    Patent number: 5804192
    Abstract: The invention relates to a process for obtaining procyanidol oligomers according to which:an appropriate plant is treated by means of an extractive mixture composed of water, of a water-miscible organic solvent capable of dissolving the procyanidol oligomers and of sodium chloride,the crude mixture of procyanidol oligomers obtained is purified by removal of the extractive mixture and extraction of the residue, the extractive mixture optionally being recycled in the stage of treatment of the plant,the procyanidol oligomers are recovered in a pure form by precipitation.
    Type: Grant
    Filed: October 5, 1995
    Date of Patent: September 8, 1998
    Assignee: Sanofi
    Inventors: Bruno Franc, Christian Hoff